Status:
COMPLETED
Follow-Up Study of Kidney Cancer Patients
Lead Sponsor:
National Cancer Institute (NCI)
Conditions:
Renal Cancer
Eligibility:
All Genders
18-80 years
Brief Summary
Background: In Central Europe, mortality rates for kidney cancers are higher and survival rates are lower than in the United States and Western Europe overall. The Central and Eastern European Renal...
Detailed Description
Previously we proposed to conduct a follow-up study of kidney cancer in the high risk region of Central and Eastern Europe. This study was conducted through the follow-up of a group of patients with k...
Eligibility Criteria
Inclusion
- INCLUSION CRITERIA:
- To be eligible for this study, patients needed to have participated as a histologically confirmed renal cancer case in the previous case-control study entitled Central European Renal Cancer Case-Control (CEERCC) Study which was completed in 2002.
- EXCLUSION CRITERIA:
- Children less than 18 are not eligible to participate in this study because there were no kidney cancer cases observed in the CEERCC Study that were less than 18 years of age.
- American Indian/Alaskan Native, Asian, Black or African American, Hispanic or Latino, and Native Hawaiian or Pacific Islander.
Exclusion
Key Trial Info
Start Date :
April 17 2008
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 17 2020
Estimated Enrollment :
1002 Patients enrolled
Trial Details
Trial ID
NCT00656955
Start Date
April 17 2008
End Date
June 17 2020
Last Update
June 18 2020
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Dept of Cancer Epidemioology Genetics, Brno, CZ
Brno, Czechia
2
Olomouc University
Olomouc, Czechia
3
National Institute of Occupational Medicine, Lodz, Poland
Lodz, Poland